Empowered Funds, LLC Neogenomics Inc Transaction History

Empowered Funds, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 26, 2020	SELL	$33.26 - $40.48 $1.45 Million - $1.77 Million	-43,690 Closed	0 $0
Q2 2020 Jul 16, 2020	BUY	$24.21 - $31.02 $1.06 Million - $1.36 Million	43,690 New	43,690 $1.35 Million
Q4 2019 Jan 27, 2020	SELL	$18.96 - $29.84 $923,617 - $1.45 Million	-48,714 Closed	0 $0
Q3 2019 Nov 01, 2019	SELL	$19.12 - $26.24 $81,623 - $112,018	-4,269 Reduced 8.06%	48,714 $931,000
Q2 2019 Jul 09, 2019	SELL	$19.57 - $24.1 $475,981 - $586,160	-24,322 Reduced 31.46%	52,983 $1.16 Million
Q1 2019 May 10, 2019	BUY	$12.14 - $20.46 $938,482 - $1.58 Million	77,305 New	77,305 $1.58 Million

295

125M

698K

120K

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $2.16B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

Get notified when there are updates to the investment portfolio of Empowered Funds, LLC, based on Form 13F filings with the SEC.

Stay updated on Empowered Funds, LLC with notifications on news.